Moreover, it was shown that the development of PAH was associated with a significant increase in the levels of p-AKT and p-ERK1/2 proteins in the lung tissues, without changes in the levels of total AKT and ERK1/2 (Fig. 1D, E). This evidence concerns the gene MAPK3 and pulmonary arterial hypertension.